News Daily News Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes L.A. McKeown October 21, 2019
News Daily News FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors Michael O'Riordan May 08, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Opinion Editor's Corner ACC 2019 Live From New Orleans: Days 2 and 3 at ACC 2019 Shelley Wood March 18, 2019